Related Experiment Video
Updated: Jun 25, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Effect of Population-Level Blood Pressure Treatment Strategies on Cardiovascular and Cognitive Outcomes
James F Burke1, Jeremy B Sussman2,3,4, Kristine Yaffe5
1Department of Neurology, Ohio State University Wexner Medical Center, Columbus (J.F.B.).
Insights
Improving blood pressure control through strategies like SPRINT reduces cardiovascular events and extends healthy life years. However, tighter BP control may not decrease dementia prevalence and could increase the number of older adults with dementia.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Public Health
Background:
- Dementia prevalence is rising, posing a significant societal challenge.
- Improved population-level blood pressure (BP) control is a potential strategy to mitigate dementia incidence.
- This study investigates the impact of stricter BP management on atherosclerotic cardiovascular disease (ASCVD) events and dementia.
Purpose of the Study:
- To evaluate the effects of optimal implementation of BP treatment guidelines on ASCVD events and dementia.
- To compare the outcomes of SPRINT and Eighth Joint National Committee (JNC8) BP treatment protocols against usual care.
- To assess the influence on global cognitive performance and years lived in optimal brain health.
Main Methods:
- Utilized the Michigan Chronic Disease Simulation Model, an open-source platform for ASCVD and dementia analysis.
- Simulated three populations: usual care, JNC8-based BP treatment, and SPRINT-based BP treatment.
- Employed nationally representative data to annually update risk factors and outcomes, including ASCVD events, cognitive performance, and dementia incidence.
Main Results:
- SPRINT-based BP treatment significantly reduced annual ASCVD events by approximately 77,000 in the US compared to usual care.
- SPRINT implementation led to greater population-level gains in years lived free of ASCVD events than JNC8.
- Optimal SPRINT-based BP management improved survival and extended years lived in optimal brain health by 0.19 and 0.3 years, respectively, for the average hypertensive patient.
Conclusions:
- While tighter BP control, particularly SPRINT-based, offers benefits in reducing ASCVD events and improving healthspan, it may not lower overall dementia prevalence.
- The study suggests that increased survival to advanced ages due to better BP management could paradoxically lead to a higher total number of older adults living with dementia.
- Tighter BP control is beneficial for individuals but unlikely to reduce dementia prevalence and may increase the number of older adults with dementia.
Background:
The large and increasing number of adults living with dementia is a pressing societal priority, which may be partially mitigated through improved population-level blood pressure (BP) control. We explored how tighter population-level BP control affects the incidence of atherosclerotic cardiovascular disease (ASCVD) events and dementia.
Methods:
Using an open-source ASCVD and dementia simulation analysis platform, the Michigan Chronic Disease Simulation Model, we evaluated how optimal implementation of 2 BP treatments based on the Eighth Joint National Committee recommendations and SPRINT (Systolic Blood Pressure Intervention Trial) protocol would influence population-level ASCVD events, global cognitive performance, and all-cause dementia. We simulated 3 populations (usual care, Eighth Joint National Committee based, SPRINT based) using nationally representative data to annually update risk factors and assign ASCVD events, global cognitive performance scores, and dementia, applying different BP treatments in each population. We tabulated total ASCVD events, global cognitive performance, all-cause dementia, optimal brain health, and years lived in each state per population.
Results:
Optimal implementation of SPRINT-based BP treatment strategy, compared with usual care, reduced ASCVD events in the United States by ≈77 000 per year and produced 0.4 more years of stroke- or myocardial infarction-free survival when averaged across all Americans. Population-level gains in years lived free of ASCVD events were greater for SPRINT-based than Eighth Joint National Committee-based treatment. Survival and years spent with optimal brain health improved with optimal SPRINT-based BP treatment implementation versus usual care: the average patient with hypertension lived 0.19 additional years and 0.3 additional years in optimal brain health. SPRINT-based BP treatment increased the number of years lived without dementia (by an average of 0.13 years/person with hypertension), but increased the total number of individuals with dementia, mainly through more adults surviving to advanced ages.
Conclusions:
Tighter BP control likely benefits most individuals but is unlikely to reduce dementia prevalence and might even increase the number of older adults living with dementia.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Errors occurring during blood pressure monitoring
Several factors...
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Pre-Procedural Guidelines for Assessing Blood Pressure

